Kali Schweitzer
Kali Schweitzer is a pharmacy management consultant with the Chicago office of Milliman. She joined the firm in 2019.
Experience
Kali’s areas of expertise include managed care, formulary management, pharmacy benefit operations, pharmaceutical pipeline, and high-cost, specialty prescription medications. She supports pharmaceutical manufacturers, employers, health plans, and Medicare Part D plan sponsors by analyzing medical and prescription drug data and providing insight into available opportunities to improve health care spend or clinical outcomes.
Prior to joining Milliman, Kali completed a post graduate year one (PGY-1) managed care pharmacy residency with a Medicaid / Medicare managed care organization. She supported a variety of programs focused on improving clinical outcomes, while also optimizing resource utilization, including formulary management, pharmacy trend analysis, quality improvement, patient engagement, and provider education.
- Navigating the Future of Pharmacy Benefit Costs: Trends, GLP-1, and Gene Therapy. Conference of Consulting Actuaries Healthcare Meeting, April 2024.
- Prescription Drug Hot Topics. Conference of Consulting Actuaries Healthcare Meeting, April 2023.
- Costs and considerations for elimination of hepatitis C virus in the United States. Milliman website, March 2023.
- Study of the impact of COVID-19 on HIV testing, diagnosis, and treatment in the United States. Milliman website, October 2022.
- Alzheimer’s disease, Aduhelm, and the impact on Medicare. Milliman website, February 2022.
- Projected U.S. National Hepatitis C Treatment Costs and Estimated Reduction to Medical Costs. Milliman website, September 2021.
- Health Plan and PBM Cost Mitigation Strategies. Conference of Consulting Actuaries Pharmacy Meeting, August 2021.
- Member, Academy of Managed Care Pharmacists
- PharmD, University of Arizona